A Houston startup is using technology to provide on-demand educators. Educational First Steps/Facebook

A Houston-area early childhood care and education startup and MassChallenge Texas in Austin 2020 participant, recently launched its 24/7 on-demand, two-sided marketplace platform that provides benefits for both parents and guardians or child care operators who need qualified educators quickly.

Due to the ongoing coronavirus pandemic, many parents are still juggling a full-time job and childcare at the same time. The launch of a marketplace platform app like OpenStaff aims to solve that problem, providing temporary or permanent childcare and teacher personnel to families and childcare operators across the Houston area, until children are able to safely go back to their daycare centers or classrooms.

"OpenStaff's Educational Mentors provide a structure that allows your child and family to retain some much-needed normalcy," says Jose Rodriguez, CEO and founder. "Our fully certified early childhood teachers and practitioners use their knowledge and experience to further a child's education while providing a safe, fun, and caring learning experience at home."

The app was launched on iOS platforms and is actively being user tested while they continue to build their database of qualified early childhood educators and substitute teachers for families and centers. All their educators comply with child care licensing regulations, completing a rigorous vetting process before they are allowed to join the platform.

"When you hire someone through our platform," says Rodriguez, "you have the peace of mind and our assurance that this teacher has been qualified, certified, background checked, and licensed in order to become a member of the OpenStaff educator community."

The early-stage startup came about from Rodriguez's first business, a childcare center that he took over six years ago with his wife. For them, the biggest challenge in this industry was staff management, dealing with unplanned absences would change plans drastically, sometimes changing teaching plans or restructuring classes.

"Even though we have an amazing team, sometimes life happens and they are not available to come into work that morning," says Rodriguez. "It was very stressful for office managers and owners as well as the rest of the team and if we were unable to find anyone to cover, even my wife or I would end up in the classroom."

That's when he started using staffing agencies for unplanned temporary workers but those, he says, are time-consuming and overpriced.

"We wanted to offer a different option that really works for everyone, not just parents during this crisis but also daycare centers," says Rodriguez. "Our app provides an open marketplace where centers can post a job by simply using their phone and receive applicants in minutes."

OpenStaff is currently focused on taking its service to the market, using the data and feedback as a way to make their offering better to then accelerate and scale, as many childcare centers continue to struggle to operate or find a sense of normalcy amid the social distancing measures that are the new normal.

"Many childcare centers have been hard hit during the coronavirus pandemic," says Rodriguez. "Many are struggling, closing their business, or operating with limited staff and children. With our app, we can, in the short term, help Houston families by providing quality education for their children."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.